Skip to main content

and
  1. Article

    Open Access

    Low-risk susceptibility alleles in 40 human breast cancer cell lines

    Low-risk breast cancer susceptibility alleles or SNPs confer only modest breast cancer risks ranging from just over 1.0 to1.3 fold. Yet, they are common among most populations and therefore are involved in the...

    Muhammad Riaz, Fons Elstrodt, Antoinette Hollestelle, Abbas Dehghan in BMC Cancer (2009)

  2. Article

    Open Access

    Standard psychological consultations and follow up for women at increased risk of hereditary breast cancer considering prophylactic mastectomy

    Women at increased (genetic) risk of breast cancer have to weigh the personal pros and cons of prophylactic mastectomy (PM) as an option to reduce their cancer risk. So far, no routine referral to a psychologi...

    Murly BM Tan, Eveline MA Bleiker in Hereditary Cancer in Clinical Practice (2009)

  3. Article

    Open Access

    A family history of breast cancer will not predict female early onset breast cancer in a population-based setting

    An increased risk of breast cancer for relatives of breast cancer patients has been demonstrated in many studies, and having a relative diagnosed with breast cancer at an early age is an indication for breast ...

    Geertruida H de Bock, Catharina E Jacobi, Caroline Seynaeve in BMC Cancer (2008)

  4. Article

    Open Access

    Clinical correlates of low-risk variants in FGFR2, TNRC9, MAP3K1, LSP1 and 8q24 in a Dutch cohort of incident breast cancer cases

    Seven SNPs in five genomic loci were recently found to confer a mildly increased risk of breast cancer.

    Petra EA Huijts, Maaike PG Vreeswijk, Karin HG Kroeze-Jansema in Breast Cancer Research (2007)

  5. Article

    Open Access

    Pathway analysis of gene signatures predicting metastasis of node-negative primary breast cancer

    Published prognostic gene signatures in breast cancer have few genes in common. Here we provide a rationale for this observation by studying the prognostic power and the underlying biological pathways of diffe...

    Jack X Yu, Anieta M Sieuwerts, Yi Zhang, John WM Martens, Marcel Smid in BMC Cancer (2007)

  6. Article

    Open Access

    GnRH and LHRgene variants predict adverse outcome in premenopausal breast cancer patients

    Breast cancer development and progression are dependent on estrogen activity. In premenopausal women, estrogen production is mainly regulated through the hypothalamic-pituitary-gonadal (HPG) axis.

    Djura Piersma, Axel PN Themmen, Maxime P Look, Jan GM Klijn in Breast Cancer Research (2007)

  7. Article

    Open Access

    Identification of women with an increased risk of develo** radiation-induced breast cancer: a case only study

    Radiation exposure at a young age is one of the strongest risk factors for breast cancer. Germline mutations in genes involved in the DNA-damage repair pathway (DDRP) may render women more susceptible to radia...

    Annegien Broeks, Linde M Braaf, Angelina Huseinovic, Anke Nooijen in Breast Cancer Research (2007)

  8. No Access

    Article

    The impact of having relatives affected with breast cancer on psychological distress in women at increased risk for hereditary breast cancer

    Purpose.Being at hereditary risk of breast cancer (BC) may lead to elevated levels of distress because of the impact of the BC-process in relatives.

    Silvia van Dooren, Caroline Seynaeve in Breast Cancer Research and Treatment (2005)

  9. Article

    Open Access

    Comment on Screening by MRI Mentioned in the Reviews by Narod and Møller

    Mieke Kriege, Cecile TM Brekelmans, Jan GM Klijn in Hereditary Cancer in Clinical Practice (2004)

  10. No Access

    Article

    One Year Follow-Up of Women Opting for Presymptomatic Testing for BRCA1 and BRCA2: Emotional Impact of the Test Outcome and Decisions on Risk Management (Surveillance or Prophylactic Surgery)

    Genetic testing enables women at risk for hereditary breast and/or ovarian cancer to find out whether they have inherited the gene mutation (BRCA1/BRCA2), and if so, to opt for frequent surveillance and/or pro...

    Litanja N Lodder, Petra G Frets, R Willem Trijsburg in Breast Cancer Research and Treatment (2002)